Photo taken fro Christopher Melani/X
Jun 23, 2024, 14:07
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
Mark Roschewski, Senior Clinician in the Lymphoid Malignancies Branch at the National Cancer Institute, shared a post on X:
“Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma | New England Journal of Medicine
Concept by Wyndham Wilson, pre-clinical rationale by Lou Staudt, and study led by Christopher Melani.
Thanks to all patients.”
Read further.
Source: Mark Roschewski/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 30, 2024, 07:37
Dec 30, 2024, 07:29
Dec 30, 2024, 07:26
Dec 30, 2024, 07:21
Dec 30, 2024, 06:48
Dec 30, 2024, 06:41
Dec 30, 2024, 03:53
Dec 30, 2024, 03:44